Shingles Vaccine

In partnership with

A new wave of research is shedding light on an unexpected connection between shingles vaccination and cognitive health. Recent findings suggest that individuals who receive the shingles vaccine may experience a significantly lower risk of developing dementia later in life — a discovery that could reshape preventive strategies for aging populations.

Go from AI overwhelmed to AI savvy professional

AI keeps coming up at work, but you still don't get it?

That's exactly why 1M+ professionals working at Google, Meta, and OpenAI read Superhuman AI daily.

Here's what you get:

• Daily AI news that matters for your career - Filtered from 1000s of sources so you know what affects your industry.

• Step-by-step tutorials you can use immediately - Real prompts and workflows that solve actual business problems.

• New AI tools tested and reviewed - We try everything to deliver tools that drive real results.

• All in just 3 minutes a day

Join 1M+ pros

Scientists have long suspected that chronic inflammation and viral reactivation may play roles in cognitive decline. The varicella‑zoster virus, which causes both chickenpox and shingles, is one such virus capable of lying dormant for decades. When it reactivates, it can trigger inflammation that may affect the nervous system.

The emerging data indicates that preventing shingles outbreaks may also reduce these inflammatory episodes, potentially protecting the brain. While the exact mechanisms are still being studied, the correlation is strong enough to spark widespread interest among neurologists and geriatric specialists.

This development comes at a critical time. Dementia rates are rising globally, and effective preventive tools remain limited. A widely available vaccine offering even modest protection could have enormous public health implications.

Experts caution that vaccination is not a cure and should be viewed as one component of a broader brain‑health strategy that includes exercise, nutrition, sleep, and social engagement. Still, the findings offer a hopeful new avenue for reducing dementia risk — and a compelling reason for eligible adults to consider shingles vaccination.